Variant report
Variant | esv2763208 |
---|---|
Chromosome Location | chr19:51361757-51377163 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:271)
- CpG islands (count:368)
- Chromatin interactive region (count:23)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51376639-51376689 | HRCEpiC | kidney: | n/a |
2 | chr19:51376639-51376689 | HCPEpiC | choroid plexus: | n/a |
3 | chr19:51376639-51376689 | HRCEpiC | kidney: | n/a |
4 | chr19:51376639-51376689 | HCPEpiC | choroid plexus: | n/a |
5 | chr19:51376711-51376761 | PFSK-1 | brain: | n/a |
6 | chr19:51362954-51363004 | CMK | blood: | n/a |
7 | chr19:51376305-51376355 | GM19239 | blood: | n/a |
8 | chr19:51375893-51375943 | HMEC | breast: | n/a |
9 | chr19:51375893-51375943 | HAEpiC | amniotic membrane: | n/a |
10 | chr19:51375975-51376025 | AG04449 | skin: | fetal |
11 | chr19:51375893-51375943 | HCM | heart: | n/a |
12 | chr19:51376711-51376761 | HRE | kidney: | n/a |
13 | chr19:51376305-51376355 | HepG2 | liver: | n/a |
14 | chr19:51375893-51375943 | ovcar-3 | ovarian: | n/a |
15 | chr19:51376639-51376689 | SAEC | small airway: | n/a |
16 | chr19:51376711-51376761 | GM06990 | blood: | n/a |
17 | chr19:51375975-51376025 | HCM | heart: | n/a |
18 | chr19:51375975-51376025 | U87 | brain: | n/a |
19 | chr19:51376639-51376689 | SK-N-SH_RA | brain: | n/a |
20 | chr19:51375975-51376025 | SK-N-SH | brain: | n/a |
21 | chr19:51376711-51376761 | HEK293 | kidney: | embryo |
22 | chr19:51375893-51375943 | BE2_C | brain: | n/a |
23 | chr19:51362954-51363004 | AG04449 | skin: | fetal |
24 | chr19:51362954-51363004 | T-47D | breast: | n/a |
25 | chr19:51375975-51376025 | MCF10A-Er-Src | breast: | n/a |
26 | chr19:51375975-51376025 | NT2-D1 | testis: | n/a |
27 | chr19:51376711-51376761 | AG09309 | skin: | n/a |
28 | chr19:51376305-51376355 | HRE | kidney: | n/a |
29 | chr19:51362954-51363004 | NH-A | brain: | n/a |
30 | chr19:51376639-51376689 | HAEpiC | amniotic membrane: | n/a |
31 | chr19:51376305-51376355 | NT2-D1 | testis: | n/a |
32 | chr19:51376711-51376761 | GM12891 | blood: | n/a |
33 | chr19:51362954-51363004 | HCM | heart: | n/a |
34 | chr19:51376711-51376761 | ProgFib | skin: | n/a |
35 | chr19:51375975-51376025 | GM12892 | blood: | n/a |
36 | chr19:51375893-51375943 | AG09319 | gingival: | n/a |
37 | chr19:51376711-51376761 | K562 | blood: | n/a |
38 | chr19:51376305-51376355 | CMK | blood: | n/a |
39 | chr19:51376305-51376355 | RPTEC | kidney: | n/a |
40 | chr19:51375893-51375943 | HIPEpiC | eye: | n/a |
41 | chr19:51375975-51376025 | SK-N-MC | brain: | n/a |
42 | chr19:51362954-51363004 | ECC-1 | luminal epithelium: | n/a |
43 | chr19:51362954-51363004 | LNCaP | prostate: | n/a |
44 | chr19:51376305-51376355 | NHBE | bronchial: | n/a |
45 | chr19:51376711-51376761 | ECC-1 | luminal epithelium: | n/a |
46 | chr19:51376711-51376761 | HNPCEpiC | eye: | n/a |
47 | chr19:51376639-51376689 | HCM | heart: | n/a |
48 | chr19:51362954-51363004 | HCPEpiC | choroid plexus: | n/a |
49 | chr19:51375975-51376025 | Hela-S3 | cervix: | n/a |
50 | chr19:51362954-51363004 | HRPEpiC | eye: | n/a |
(count:23 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51304609..51306966-chr19:51367482..51368992,2 | K562 | blood: | |
2 | chr19:51321017..51323255-chr19:51371295..51373304,2 | K562 | blood: | |
3 | chr19:51296075..51301998-chr19:51356744..51362542,6 | K562 | blood: | |
4 | chr19:51372696..51375845-chr19:51379331..51383690,4 | K562 | blood: | |
5 | chr19:51368140..51370894-chr19:51374787..51377446,2 | K562 | blood: | |
6 | chr19:51297446..51299225-chr19:51366827..51368327,2 | K562 | blood: | |
7 | chr19:51306397..51308318-chr19:51369356..51371839,3 | K562 | blood: | |
8 | chr19:51306448..51310717-chr19:51372415..51375235,4 | K562 | blood: | |
9 | chr19:51297152..51303261-chr19:51371696..51377038,8 | K562 | blood: | |
10 | chr19:51296429..51299323-chr19:51371370..51374659,5 | K562 | blood: | |
11 | chr19:51357036..51359408-chr19:51369066..51370835,2 | K562 | blood: | |
12 | chr19:51367668..51370894-chr19:51374787..51378552,5 | K562 | blood: | |
13 | chr19:51304876..51308314-chr19:51372660..51375800,4 | MCF-7 | breast: | |
14 | chr19:51335920..51338243-chr19:51361874..51364781,2 | K562 | blood: | |
15 | chr19:51292849..51296626-chr19:51372637..51375537,3 | K562 | blood: | |
16 | chr19:51303704..51305752-chr19:51372094..51375734,4 | K562 | blood: | |
17 | chr19:51373828..51375364-chr19:51376061..51378763,2 | K562 | blood: | |
18 | chr19:51357627..51359895-chr19:51362884..51364661,2 | K562 | blood: | |
19 | chr19:51373828..51375364-chr19:51376061..51378763,2 | K562 | blood: | |
20 | chr19:51303704..51306185-chr19:51373080..51375734,4 | K562 | blood: | |
21 | chr19:51374203..51378024-chr19:51378917..51381093,3 | MCF-7 | breast: | |
22 | chr19:51339489..51342221-chr19:51372439..51375548,3 | K562 | blood: | |
23 | chr19:51306202..51308468-chr19:51372838..51375377,2 | K562 | blood: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KLK4-2 | chr19:51374583-51374634 | l_1707_chr19:51368933-51375786_hela |
2 | lnc-KLK4-2 | chr19:51368934-51369149 | l_1707_chr19:51368933-51375786_hela |
3 | lnc-KLK2-1 | chr19:51376689-51376775 | NONHSAT067387 |
4 | lnc-KLK3-2 | chr19:51363767-51364031 | NONHSAT067383 |
5 | lnc-KLK4-2 | chr19:51375702-51375786 | l_1707_chr19:51368933-51375786_hela |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLK2 | TF binding region |
KLK2 | CpG island |
ENSG00000268375 | chromatin interactions |
ENSG00000142515 | chromatin interactions |
ENSG00000220988 | chromatin interactions |
ENSG00000221241 | chromatin interactions |
ENSG00000174562 | chromatin interactions |
ENSG00000167747 | chromatin interactions |
ENSG00000221381 | chromatin interactions |
ENSG00000142513 | chromatin interactions |
ENSG00000180279 | chromatin interactions |
ENSG00000167751 | chromatin interactions |
ENSG00000267880 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17632542 | chr19:51361757-51361758 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | disease |
2 | rs372148450 | chr19:51361767-51361768 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs150769385 | chr19:51361768-51361769 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs554107787 | chr19:51361775-51361776 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs376510386 | chr19:51361776-51361777 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs572619039 | chr19:51361788-51361789 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs376934756 | chr19:51361795-51361796 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs139172057 | chr19:51361809-51361810 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs1803129 | chr19:51361821-51361822 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs546294568 | chr19:51361822-51361823 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs370658603 | chr19:51361824-51361825 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs187449592 | chr19:51361826-51361827 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs191588971 | chr19:51361827-51361828 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs146528783 | chr19:51361829-51361830 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs61729813 | chr19:51361850-51361851 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs562766163 | chr19:51361860-51361861 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs201047135 | chr19:51361878-51361879 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs111901464 | chr19:51361879-51361880 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs146258393 | chr19:51361896-51361897 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs574463961 | chr19:51361897-51361898 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs115684571 | chr19:51361900-51361901 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs369129680 | chr19:51361910-51361911 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs61155209 | chr19:51361918-51361919 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs266875 | chr19:51361937-51361938 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs537446280 | chr19:51361946-51361947 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs549395279 | chr19:51361949-51361950 | Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs568722732 | chr19:51361959-51361960 | Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs535742056 | chr19:51361968-51361969 | Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs144992202 | chr19:51361977-51361978 | Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs34750956 | chr19:51361996-51361997 | Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs540044849 | chr19:51362000-51362001 | Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs200214438 | chr19:51362025-51362026 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs558270687 | chr19:51362026-51362027 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs576655636 | chr19:51362065-51362066 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs527909366 | chr19:51362077-51362078 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs149172274 | chr19:51362084-51362085 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs561972778 | chr19:51362118-51362119 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs182679925 | chr19:51362124-51362125 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs541729980 | chr19:51362132-51362133 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs560406069 | chr19:51362173-51362174 | Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs142342538 | chr19:51362202-51362203 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs545641622 | chr19:51362245-51362246 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs78779935 | chr19:51362251-51362252 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs531342101 | chr19:51362298-51362299 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs11084034 | chr19:51362304-51362305 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs151258801 | chr19:51362305-51362306 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs79435423 | chr19:51362325-51362326 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs377466753 | chr19:51362326-51362327 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs566400170 | chr19:51362351-51362352 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs540034215 | chr19:51362388-51362389 | Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17160897 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51360600-51362800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr19:51360600-51363000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr19:51361000-51362000 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
4 | chr19:51361400-51362800 | Enhancers | Pancreas | Pancrea |
5 | chr19:51361400-51364800 | Enhancers | Esophagus | oesophagus |
6 | chr19:51361600-51363000 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr19:51361800-51362000 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
8 | chr19:51361800-51362600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
9 | chr19:51362000-51362200 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
10 | chr19:51362000-51362200 | Bivalent Enhancer | Fetal Intestine Large | intestine |
11 | chr19:51362000-51362800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
12 | chr19:51362200-51362400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
13 | chr19:51362400-51362600 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
14 | chr19:51362600-51363000 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
15 | chr19:51362800-51364400 | Weak transcription | Pancreas | Pancrea |
16 | chr19:51364400-51364600 | ZNF genes & repeats | Pancreas | Pancrea |
17 | chr19:51364600-51364800 | Weak transcription | Pancreas | Pancrea |
18 | chr19:51364600-51365000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr19:51372600-51373000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
20 | chr19:51373200-51374200 | Bivalent/Poised TSS | A549 | lung |
21 | chr19:51373400-51374200 | Bivalent/Poised TSS | HepG2 | liver |
22 | chr19:51373400-51374400 | Flanking Active TSS | K562 | blood |
23 | chr19:51373600-51374200 | Enhancers | Placenta | Placenta |
24 | chr19:51376400-51376600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |